I honestly don't see how DCB's announcements could extend timelines even further. We've been running our EMD AML trial for a year and yet to recruit a patient. The last update it appeared as though recruitment in the Sheba trial had also slowed a bit. None of that is on DCB. Nor do I expect DCB is going to be re-inventing the 3 pillars - he's still talking about the same things... cardioprotection, FTO, AML, etc.
If anything, I expect (hope) DCB will provide plans to progress our trials and timelines for possible collaborations/partnerships/buyout where we currently don't have any.
I honestly don't see how DCB's announcements could extend...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.66 |
Change
-0.030(1.78%) |
Mkt cap ! $282.0M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.65 | $126.2K | 76.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 120 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.67 | 500 | 1 |
View Market Depth
| Last trade - 13.57pm 03/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |